Learn About Cardiac Non-Invasive Testing On Webcast

OSUWexnerbloglogo2014 Learn About Cardiac Non-Invasive Testing On Webcast. Today on MedNet21, we are going to update you on the currently used tests to non-invasively identify patients with ischemic heart disease. To tell us about stress test options, we’re pleased to welcome cardiologist and Assistant Professor of Internal Medicine Dr. Bryan Lee. And then to tell us about the role of cardiac CT and MRI, we have cardiologist and Assistant Professor of Internal Medicine, Dr. Salman Bhatti.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: describe how to assess the pre-test likelihood of coronary artery disease by history; and understand the advantages and pitfalls between the different modalities; recognize when it is appropriate to order a stress test; and understand how different stress modalities compare with each other, their advantages and disadvantages and when to use one over the other.

You’ll also learn about the following:

  • Cardiac stress test selection
  • Cardiac CT & MRI
  • Common indications for cardiac MRI
  • Training required to read cardiac CT & MRI

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Get the Latest Information on Medical Marijuana with On-line Education

OSUWexnerbloglogo2014 Get the Latest Information on Medical Marijuana with On-line Education. One of the most recent states to legalize medical marijuana is Ohio where a new medical marijuana law went into effect earlier this month. But it is not without controversy, however. And it is really difficult to find objective, scientific data on the medicinal effects of marijuana. On this CME webcast, we’ve brought in two of the Ohio State University’s top experts on marijuana to give us an unbiased review of medical marijuana and we’re going to frame the discussion in the context of Ohio’s new medical marijuana law. To review the pharmacology of marijuana, palliative medicine clinical pharmacist, and to tell us more about the medical uses of marijuana is Professor of Internal Medicine and the long-standing chairman of the OSU Pharmacy and Therapeutics committee, Dr. Harrison Weed.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the currently accepted appropriate uses of medical marijuana; and UNDERSTAND the potential
adverse consequences of medical marijuana.

You’ll also learn about the following:

  • Current pharmacologic uses of cannabinoids
  • Medicinal properties of marijuana
  • Hemp versus marijuana
  • The Ohio Automated Rx Reporting System (OARRS)
  • Hospital approaches to inpatient use of medical marijuana
  • Purity testing and labeling

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Webcast Teaches on Anticoagulation and New Anticoagulants

OSUWexnerbloglogo2014 Webcast Teaches on Anticoagulation and New Anticoagulants. Now, we have even more anticoagulants and with all of the choices comes a lot of confusion. On this CME webcast, joining our moderator, to demystify all of the new anticoagulants and to give us some direction of when to choose one versus another is hematologist and Assistant Professor of Internal Medicine from the Ohio State University, Dr. Tzu-Fei Wang.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: State the differences of old anticoagulation and new direct oral anticoagulants and know the four approved direct oral anticoagulant; and UNDERSTAND the indications, laboratory testing, and precautions when prescribing direct oral anticoagulants.

You’ll also learn about the following:

  • The problem with Coumadin
  • Currently available direct oral anticoagulants
  • When Coumadin is the best option
  • Mitigating malpractice risk when prescribing direct oral anticoagulants

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Teaches Viewers About Acute Hepatitis

OSUWexnerbloglogo2014 CME Webcast Teaches Viewers About Acute Hepatitis. For his discovery of the virus we now know as hepatitis B and his discovery of a vaccine against it, Dr. Barry Blumberg was awarded the Nobel Prize. At the time of his death, the Scientific Director of the Fox Chase Cancer Center where Blumberg worked said of him: “I think it’s fair to say that Barry prevented more cancer deaths than any person who’s ever lived.” Hepatitis B is only one of a number of viruses as well as drugs and other conditions that can cause acute hepatitis. Here in the studio, with our moderator, to tell us about the different causes of acute hepatitis is hepatologist and Assistant Professor of Internal Medicine, Dr. Sean Kelly. And then to discuss the fundamentals of management of patients with acute liver failure, Associate Professor of Internal Medicine and the Director of the Section of Hepatology at the Ohio State University, Dr. James Hanje.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: IDENTIFY the most common causes of acute hepatitis and characteristics of each type; and IDENTIFY the difference between abnormal liver function tests/acute hepatitis and Acute Liver Failure.

You’ll also learn about the following:

  • Common causes of acute hepatitis
  • New developments in the management of acute liver failure
  • Initial lab testing in patients with acute hepatitis
  • The role of radiographic imaging in evaluation of acute hepatitis
  • Use of the ammonia level in acute liver failure
  • When and how to assess intracranial hypertension

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.